cdmo.directory
← Compare landing

Cell and Gene Therapy Catapult vs Enable Biotech Ltd

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ct/enablebiotech

CategoryCell and Gene Therapy CatapultEnable Biotech Ltd
Listed sitecdmocdmo
SummaryUK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.Enable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024.
Services
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Upstream Processing
  • Downstream Processing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
  • Gene Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Rare Disease
Data not yet provided.
Locations
  • Headquarters, Stevenage, Hertfordshire, United Kingdom
  • London, London, England, United Kingdom
  • Braintree, Braintree, Essex, United Kingdom
  • Edinburgh, Edinburgh, Scotland, United Kingdom
  • Headquarters, United Kingdom
  • Headquarters, Zug, Switzerland
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.